{"title":"人TMEM16F的离子通道功能与磷脂通过其亚基腔的转运有关。","authors":"Teppei Kageyama, Takahiro Shimizu, Kanon Shirai, Shota Nabeshima, Shigeki Ozawa, Takuto Fujii, Yoshiki Yonekawa, Hideki Sakai","doi":"10.1248/bpb.b24-00859","DOIUrl":null,"url":null,"abstract":"<p><p>Transmembrane protein 16F (TMEM16F), identified as the causative gene for Scott syndrome, which causes blood coagulation disorders, is known to function as not only a scramblase that bi-directionally transports phospholipids in the lipid bilayer but also a Ca<sup>2+</sup>-activated ion channel with low intracellular Ca<sup>2+</sup> sensitivity. However, how the dual functions of TMEM16F are controlled remains poorly understood. In this study, we investigated the properties of amino acid residues in human TMEM16F involved in the linkage between phospholipid and ion transports and the regulation of their transports using flow cytometry and whole-cell patch-clamp recordings. We demonstrated that ion and phospholipid transports induced by elevation of intracellular Ca<sup>2+</sup> concentration were tightly coupled in human embryonic kidney HEK293T cells overexpressing wild-type TMEM16F or its mutants. Mutations of amino acid residues in the hydrophilic subunit cavity of TMEM16F indicated that both substrates were transported through its subunit cavity. Importantly, the tail current analysis suggests that conformational changes of TMEM16F by the channel gating are required for its phospholipid transport. These results suggest that ion channel activities of human TMEM16F modulate its scramblase activities.</p>","PeriodicalId":8955,"journal":{"name":"Biological & pharmaceutical bulletin","volume":"48 5","pages":"595-605"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ion Channel Function of Human TMEM16F Is Associated with Phospholipid Transport through Its Subunit Cavity.\",\"authors\":\"Teppei Kageyama, Takahiro Shimizu, Kanon Shirai, Shota Nabeshima, Shigeki Ozawa, Takuto Fujii, Yoshiki Yonekawa, Hideki Sakai\",\"doi\":\"10.1248/bpb.b24-00859\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Transmembrane protein 16F (TMEM16F), identified as the causative gene for Scott syndrome, which causes blood coagulation disorders, is known to function as not only a scramblase that bi-directionally transports phospholipids in the lipid bilayer but also a Ca<sup>2+</sup>-activated ion channel with low intracellular Ca<sup>2+</sup> sensitivity. However, how the dual functions of TMEM16F are controlled remains poorly understood. In this study, we investigated the properties of amino acid residues in human TMEM16F involved in the linkage between phospholipid and ion transports and the regulation of their transports using flow cytometry and whole-cell patch-clamp recordings. We demonstrated that ion and phospholipid transports induced by elevation of intracellular Ca<sup>2+</sup> concentration were tightly coupled in human embryonic kidney HEK293T cells overexpressing wild-type TMEM16F or its mutants. Mutations of amino acid residues in the hydrophilic subunit cavity of TMEM16F indicated that both substrates were transported through its subunit cavity. Importantly, the tail current analysis suggests that conformational changes of TMEM16F by the channel gating are required for its phospholipid transport. These results suggest that ion channel activities of human TMEM16F modulate its scramblase activities.</p>\",\"PeriodicalId\":8955,\"journal\":{\"name\":\"Biological & pharmaceutical bulletin\",\"volume\":\"48 5\",\"pages\":\"595-605\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Biological & pharmaceutical bulletin\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1248/bpb.b24-00859\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biological & pharmaceutical bulletin","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1248/bpb.b24-00859","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Ion Channel Function of Human TMEM16F Is Associated with Phospholipid Transport through Its Subunit Cavity.
Transmembrane protein 16F (TMEM16F), identified as the causative gene for Scott syndrome, which causes blood coagulation disorders, is known to function as not only a scramblase that bi-directionally transports phospholipids in the lipid bilayer but also a Ca2+-activated ion channel with low intracellular Ca2+ sensitivity. However, how the dual functions of TMEM16F are controlled remains poorly understood. In this study, we investigated the properties of amino acid residues in human TMEM16F involved in the linkage between phospholipid and ion transports and the regulation of their transports using flow cytometry and whole-cell patch-clamp recordings. We demonstrated that ion and phospholipid transports induced by elevation of intracellular Ca2+ concentration were tightly coupled in human embryonic kidney HEK293T cells overexpressing wild-type TMEM16F or its mutants. Mutations of amino acid residues in the hydrophilic subunit cavity of TMEM16F indicated that both substrates were transported through its subunit cavity. Importantly, the tail current analysis suggests that conformational changes of TMEM16F by the channel gating are required for its phospholipid transport. These results suggest that ion channel activities of human TMEM16F modulate its scramblase activities.
期刊介绍:
Biological and Pharmaceutical Bulletin (Biol. Pharm. Bull.) began publication in 1978 as the Journal of Pharmacobio-Dynamics. It covers various biological topics in the pharmaceutical and health sciences. A fourth Society journal, the Journal of Health Science, was merged with Biol. Pharm. Bull. in 2012.
The main aim of the Society’s journals is to advance the pharmaceutical sciences with research reports, information exchange, and high-quality discussion. The average review time for articles submitted to the journals is around one month for first decision. The complete texts of all of the Society’s journals can be freely accessed through J-STAGE. The Society’s editorial committee hopes that the content of its journals will be useful to your research, and also invites you to submit your own work to the journals.